. (TOCA)
$0 0 (0.00%)
Market Cap: $0
As of 12/31/69 07:00 PM EST. Market closed.
. (TOCA)
$0
0 (0.00%)
Market Cap: $0
As of 12/31/69 07:00 PM EST. Market closed.
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open in: 
Open in:
INSIDER TRANSACTIONS FOR
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Wagner Paul A. | See Remarks | Apr 01, 2023 | Option Exercise | $1.01 | 11,046 | 11,156 | 1,399,253 | Apr 04, 2023, 08:19 PM |
| Riley Antony A | Chief Financial Officer | Apr 01, 2023 | Option Exercise | $1.01 | 3,241 | 3,273 | 18,628 | Apr 04, 2023, 08:18 PM |
| Chen Hubert C | See remarks | Apr 01, 2023 | Option Exercise | $1.01 | 2,593 | 2,619 | 4,907 | Apr 04, 2023, 08:17 PM |
| Wagner Paul A. | See Remarks | Dec 16, 2022 | Buy | $1.07 | 44,024 | 47,000 | 1,379,049 | Dec 19, 2022, 04:21 PM |
| Wagner Paul A. | See Remarks | Dec 15, 2022 | Buy | $1.03 | 55,976 | 57,672 | 1,335,025 | Dec 19, 2022, 04:21 PM |
| Wagner Paul A. | See Remarks | Sep 07, 2021 | Sale | $4.35 | 1,000,000 | 4,347,100 | 1,279,049 | Sep 08, 2021, 05:02 PM |
| Riley Antony A | Chief Financial Officer | Sep 07, 2021 | Sale | $4.24 | 25,000 | 106,105 | 14,581 | Sep 07, 2021, 04:09 PM |
| DARCY THOMAS E | Director | Jan 13, 2021 | Option Exercise | $9.59 | 500 | 4,793 | 2,358 | Jan 14, 2021, 07:17 PM |
| Riley Antony A | Chief Financial Officer | Jun 26, 2020 | Buy | $14.52 | 4,700 | 68,225 | 34,065 | Jun 30, 2020, 08:07 PM |
| Riley Antony A | Chief Financial Officer | Jun 29, 2020 | Buy | $14.11 | 2,000 | 28,220 | 36,065 | Jun 30, 2020, 08:07 PM |
| Wagner Paul A. | See Remarks | Jun 25, 2020 | Buy | $14.48 | 7,000 | 101,356 | 2,279,049 | Jun 29, 2020, 08:13 PM |
| Oliveira Steven Michael | 10% Owner | Apr 14, 2020 | Buy | $1.19 | 74,301 | 88,418 | 2,873,450 | Apr 14, 2020, 05:00 PM |
| Oliveira Steven Michael | 10% Owner | Mar 02, 2020 | Buy | $1.35 | 65,149 | 87,756 | 2,799,149 | Mar 03, 2020, 04:17 PM |
| Hasnain Faheem | Director | May 30, 2019 | Buy | $4.66 | 43,000 | 200,315 | 245,857 | Jun 03, 2019, 04:11 PM |
| Jolly Douglas | EVP, Research & Pharm Devel | Dec 10, 2018 | Option Exercise | $8.19 | 732 | 5,995 | 393,478 | May 29, 2019, 04:32 PM |
| Jolly Douglas | EVP, Research & Pharm Devel | Jun 08, 2018 | Option Exercise | $8.19 | 703 | 5,758 | 392,746 | May 29, 2019, 04:32 PM |
| FOLETTA MARK G | EVP & Chief Financial Officer | May 28, 2019 | Buy | $4.30 | 5,000 | 21,475 | 15,042 | May 29, 2019, 04:29 PM |
| Duvall Martin J | Chief Executive Officer | May 28, 2019 | Buy | $4.34 | 5,000 | 21,679 | 13,605 | May 29, 2019, 04:25 PM |
| GRUBER HARRY E | President, Science&Innovation | May 24, 2019 | Buy | $4.56 | 5,000 | 22,782 | 9,744 | May 29, 2019, 04:22 PM |
| Das Asha | SVP & Chief Medical Officer | Dec 08, 2017 | Option Exercise | $8.50 | 2,500 | 21,250 | 5,000 | Dec 14, 2017, 09:10 PM |
| FOLETTA MARK G | EVP & Chief Financial Officer | Dec 08, 2017 | Option Exercise | $8.50 | 2,500 | 21,250 | 7,500 | Dec 14, 2017, 09:07 PM |
| Duvall Martin J | Chief Executive Officer | Dec 08, 2017 | Option Exercise | $8.50 | 2,500 | 21,250 | 6,071 | Dec 14, 2017, 09:02 PM |
| GRUBER HARRY E | President, Research & Devel | Dec 08, 2017 | Option Exercise | $8.50 | 2,500 | 21,250 | 2,500 | Dec 14, 2017, 08:51 PM |
| Jolly Douglas | EVP, Research & Pharm Devel | Dec 08, 2017 | Option Exercise | $8.50 | 739 | 6,282 | 392,043 | Dec 14, 2017, 08:46 PM |
| Das Asha | SVP & Chief Medical Officer | Apr 19, 2017 | Buy | $10.00 | 2,500 | 25,000 | 2,500 | Apr 21, 2017, 05:44 PM |
| FOLETTA MARK G | EVP & Chief Financial Officer | Apr 19, 2017 | Buy | $10.00 | 5,000 | 50,000 | 5,000 | Apr 21, 2017, 05:42 PM |
| GRUBER HARRY E | President, Research & Devel | Apr 19, 2017 | Buy | $10.00 | 25,000 | 250,000 | 417,753 | Apr 21, 2017, 05:41 PM |
| Duvall Martin J | Chief Executive Officer | Apr 19, 2017 | Option Exercise | $10.00 | 3,571 | 35,710 | 3,571 | Apr 21, 2017, 05:39 PM |
| BERGER FRANKLIN M | Director | Apr 19, 2017 | Option Exercise | $10.00 | 25,335 | 253,350 | 25,335 | Apr 21, 2017, 05:37 PM |
| SCHIMMEL PAUL | Director | Apr 19, 2017 | Buy | $10.00 | 10,000 | 100,000 | 13,623 | Apr 21, 2017, 05:34 PM |
| Hasnain Faheem | Director | Apr 19, 2017 | Option Exercise | $10.00 | 102,857 | 1,028,570 | 102,857 | Apr 21, 2017, 05:28 PM |
| Hasnain Faheem | Director | Apr 19, 2017 | Buy | $10.00 | 100,000 | 1,000,000 | 202,857 | Apr 21, 2017, 05:28 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Wagner Paul A. | See Remarks | 04/01/2023 | 11,156 |
| Riley Antony A | Chief Financial Officer | 04/01/2023 | 3,273 |
| Chen Hubert C | See remarks | 04/01/2023 | 2,619 |
| Wagner Paul A. | See Remarks | 12/16/2022 | 47,000 |
| Wagner Paul A. | See Remarks | 12/15/2022 | 57,672 |
| Wagner Paul A. | See Remarks | 09/07/2021 | 4,347,100 |
| Riley Antony A | Chief Financial Officer | 09/07/2021 | 106,105 |
| DARCY THOMAS E | Director | 01/13/2021 | 4,793 |
| Riley Antony A | Chief Financial Officer | 06/26/2020 | 68,225 |
| Riley Antony A | Chief Financial Officer | 06/29/2020 | 28,220 |
| Wagner Paul A. | See Remarks | 06/25/2020 | 101,356 |
| Oliveira Steven Michael | 10% Owner | 04/14/2020 | 88,418 |
| Oliveira Steven Michael | 10% Owner | 03/02/2020 | 87,756 |
| Hasnain Faheem | Director | 05/30/2019 | 200,315 |
| Jolly Douglas | EVP, Research & Pharm Devel | 12/10/2018 | 5,995 |
| Jolly Douglas | EVP, Research & Pharm Devel | 06/08/2018 | 5,758 |
| FOLETTA MARK G | EVP & Chief Financial Officer | 05/28/2019 | 21,475 |
| Duvall Martin J | Chief Executive Officer | 05/28/2019 | 21,679 |
| GRUBER HARRY E | President, Science&Innovation | 05/24/2019 | 22,782 |
| Das Asha | SVP & Chief Medical Officer | 12/08/2017 | 21,250 |
| FOLETTA MARK G | EVP & Chief Financial Officer | 12/08/2017 | 21,250 |
| Duvall Martin J | Chief Executive Officer | 12/08/2017 | 21,250 |
| GRUBER HARRY E | President, Research & Devel | 12/08/2017 | 21,250 |
| Jolly Douglas | EVP, Research & Pharm Devel | 12/08/2017 | 6,282 |
| Das Asha | SVP & Chief Medical Officer | 04/19/2017 | 25,000 |
| FOLETTA MARK G | EVP & Chief Financial Officer | 04/19/2017 | 50,000 |
| GRUBER HARRY E | President, Research & Devel | 04/19/2017 | 250,000 |
| Duvall Martin J | Chief Executive Officer | 04/19/2017 | 35,710 |
| BERGER FRANKLIN M | Director | 04/19/2017 | 253,350 |
| SCHIMMEL PAUL | Director | 04/19/2017 | 100,000 |
| Hasnain Faheem | Director | 04/19/2017 | 1,028,570 |
| Hasnain Faheem | Director | 04/19/2017 | 1,000,000 |
Load More Insider Transactions